TERUMO HydroPearl embolization microspheres recalled for manufacturing process deviation
MICROVENTION is recalling TERUMO HydroPearl Compressible Microspheres because manufacturing and quality processes were not followed during production. The recall affects 22 units distributed in seven U.S. states.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II precautionary recall with no reported illnesses, injuries, or identified specific hazard. Manufacturing process non-compliance without confirmed product defects or safety impacts fits the precautionary recall category.
Plain-English summary
MICROVENTION INC. is recalling the TERUMO HydroPearl Compressible Microspheres for Embolisation (Model HP2S0600, Lot Number 0000342047). The product is used in embolization procedures. The recall affects 22 units distributed across the United States.
The recall was initiated because the prescribed manufacturing and quality processes were not followed during production. As a result, the product was inadvertently distributed despite these process deviations.
The affected product was distributed to healthcare facilities in Arizona, Illinois, Louisiana, North Carolina, Tennessee, Virginia, and Wisconsin. Patients or healthcare providers who have received this product should consult with their healthcare provider or contact MICROVENTION INC. for further guidance. Additional information is available on the FDA website.
The recalled product
- Product
- TERUMO HydroPearl Compressible Microspheres for Embolisation REF 8HP2S600
- Manufacturer
- MICROVENTION INC.
- Affected units
- 22
Distribution
Related recalls
Same manufacturer · MICROVENTION INC.
See all →- HighMicrovention Recalls Bobby Balloon Guide Catheters Due to Pinhole Defects
FDA (Devices) · 2026-08-19
- SevereLVIS Intraluminal Support Device Stent Recalled Dimensional Nonconformance
FDA (Devices) · 2026-05-20
- HighFlow diverter devices recalled over tantalum defect affecting vessel wall apposition
FDA (Devices) · 2025-10-22
- HighLIFEPEARL microspheres are smaller than specification, risking non-targeted embolization
FDA (Devices) · 2025-08-06
- HighLVIS Intraluminal Support Device May Fail to Deploy Properly
FDA (Devices) · 2025-02-19
Same hazard · manufacturing process deviation
See all →- ModerateAntifungal Drug Recalled for Manufacturing Process Deviations
FDA (Drugs) · 2025-05-28
- ModerateArtridon Topical Analgesic Recalled for Manufacturing Process Deviations
FDA (Drugs) · 2025-05-28
- ModerateProchlorperazine Maleate Tablets Recalled for Manufacturing Process Deviations
FDA (Drugs) · 2025-04-16
- ModerateAripiprazole Tablets Recalled Following FDA Inspection for Manufacturing Deviations
FDA (Drugs) · 2023-03-08
- ModerateAntacid Suspension Recalled Due to Manufacturing Process Control Deviations
FDA (Drugs) · 2022-09-14